ACSL3, a pivotal enzyme in lipid metabolism, exhibits a dual function—facilitating cancer development while suppressing ferroptosis—highlighting the intricacies of metabolic reprogramming in tumour advancement and medication resistance. This evidence concerns the gene ACSL3 and cancer.